

.png)
CAPI Oncology Summit
On the Future of Oncology & Hematology
April 5, 2025 - Orlando, Florida
Caribe Royale Resort - Convention Center
​​
​
​
​
Join us at the exclusive CAPI Oncology & Hematology Summit, an annual event bringing together Central Florida's brightest minds in the fields of oncology and hematology. This invitation-only experience is taking place on April 5, 2025, at the Caribe Royale Resort & Convention Center in Orlando, Florida (7:30am to 2pm). With a handpicked group of 30 top oncologists and hematologists, this power-packed half-day (non CME) gathering promises an immersive learning experience blended with a unique opportunity to collaborate with industry innovators.
​​
As a specially invited guest, your presence at the CAPI Oncology & Hematology Summit is a testament to your expertise and leadership in the field of oncology and hematology. We are pleased to inform you that your conference fees will be fully hosted by CAPI. Start your day with a delightful breakfast as you network with fellow industry leaders, followed by a series of enlightening sessions led by our distinguished panel of speakers. Our program ends promptly at 1pm and is followed by a delightful lunch.
​



sponsors
The CAPI Oncology Summit provides a one-day intensive learning canvas, ideal to showcase your unique expertise in the field of oncology and hematology healthcare. Engagement opportunities include designing a speaker session, activating your brand in the exhibitor showcase, and other customized networking experiences.
speakers
The CAPI Oncology Summit is honored to welcome a list of esteemed experts. As a speaker please use the code provided in your agreement to access to the speaker portal to download your speaker kit, upload presentation materials, and access key information about your engagement.













.jpg)



The Program
CAPI Oncology Summit
April 5, 2025
Caribe Royale Resort - Orlando
Sessions Located In: Antiqua 1 - 2
Exhibition and Meals Located In: Antiqua 3 - 4
​
Our program is being curated by our co-chairs in alignment with interests of CAPI physician attendees.
​
7:30am 8:00am - Registration and Breakfast
​
7:55am - 8:00am - Opening Remarks (CAPI Co Chairs)
​​
8:00am - 8:30am - Session 1 - SOBI - The importance of thrombocytopenia in myelofibrosis and the role of VONJO(r) (pacritinib) Speaker: Daniel Landau, MD
​​​
8:30am - 9:00am - Session 2 - Genentech - Itovebi (Inavolisb), Explain the Label
Speaker: Carolyn Lavender, MSN, AOCNP, APRN
​
9:00am - 9:30am - Session 3 - Beigene - Brukinsa (zanubrutinib) in Hematologic Malignancies
Speaker: Daniel Kerr, MD
​
​9:30am - 10:00am - Session 4 - Bayer Pharmaceuticals
Exploring the Role of darolutamide in mHSPC in Combination with Docetaxel and in nmCRPC
Speaker: Daniel Landau, MD
​
10:00am - 10:30am - Session 5 - Daiichi Sankyo, Inc.
HER2 Expression Informs Clinical Decision-Making in HR+/HER2-Low and HER2-Ultralow mBC
Speaker: Nikita Shah, MD
​
10:30am - 11:00am - Power Break
​
11:00am - 11:30am - Session 6 - Blueprint Medicines
Understanding AYVAKIT (avapritinib) for Indolent Systemic Mastocytosis(ISM)
Speaker: To be announced
​​
11:30am - 12:00pm - Session 7 - Genentech - Updates to DLBCL, current and future pipeline
Speaker: Jessica Hurley, Pharm D
​
12:00pm - 12:30pm - Session 8 - Sanofi - Now approved: The first and only FDA approved anti CD-38+ VRd therapy in patients with NDMM not eligible for transplant
Speaker: Raymond Thertulien,MD
​
12:30pm - 1:00pm - Cumulative Buffer
​​
1:00pm - 2:00 - Lunch
​

Conference Leadership

.png)
.png)
